MetaCap

InMode Ltd. (INMD)

NASDAQ: INMDHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

12.42-0.28 (-2.20%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

INMD stock chart

Technical analysis

Key statistics

All statistics
Market cap
$714.70M
52-week range
12.40 – 16.67
Day range
12.40 – 12.67
Volume / Avg
707.55K / 529.24K
Beta
—

52-week range

$12.40$16.67

INMD stock today

InMode (INMD) closed at $12.42 on Nov 20, down 2.20% (-$0.28), versus the S&P 500's 3.70% decline. At this level, INMD sits near the bottom of its 52-week range of $12.40 to $16.67: 25.5% below the high, set on Feb 2, 2026 and 0.2% above the low. INMD is down 15.5% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 11.7%.

InMode trades at 10.4x its trailing twelve-month earnings per share of $1.19. Its forward P/E of 9.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About InMode

Company profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.

Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
CEO
Mr. Moshe Mizrahy
Headquarters
Yokne'am
Employees
660
IPO year
2019

Financial highlights

Full financials

In fiscal 2025, InMode generated $370.5 million in revenue, down 6.2% from fiscal 2024, its first annual decline since 2024. Net income was $93.8 million (-48.2% year over year), for a net margin of 25.3% versus a median of 40.2% in the prior 5 years. Gross margin was 78.5% (down from 80.3%) and operating margin 23.0%.

InMode annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$370.50M$394.82M$492.05M$454.27M$357.56M
Growth-6.16%-19.76%+8.32%+27.05%+73.49%
Net income$93.83M$181.28M$197.92M$161.52M$164.97M
EPS (diluted)$1.43$2.25$2.30$1.89$1.92

Analyst forecast

Forecast

Consensus (5 analysts)

hold

Avg. price target

$14.67+18.12%

  • Strong buy 0
  • Buy 0
  • Hold 5
  • Sell 0
  • Strong sell 0

Target range

Low $14.00High $15.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 11, 2026
EPS actual vs est.
$0.32 vs —

INMD news

All INMD news

InMode peers

Health Care sector
INMD peer companies
CompanyPrice% ChgMarket capCompare
CBLLCeriBell Inc.27.39+6.37%$1.06Bvs INMD
CVCapsoVision Inc.6.11-3.17%$327.56Mvs INMD
ELMDElectromed Inc.22.98-1.20%$187.84Mvs INMD
FOCLEDAP TMS S.A. ADR2.61-7.45%$123.25Mvs INMD
VANIVivani Medical Inc.1.14+4.59%$102.83Mvs INMD
STXSStereotaxis Inc.0.9422-6.71%$95.03Mvs INMD
HSDTSolana Company Class A1.49-10.24%$93.70Mvs INMD
NRXSNeuraxis Inc.4.22-6.22%$59.90Mvs INMD

Indexes, lists and sector

InMode stock FAQ

What is InMode's stock price today?

INMD last traded at $12.42 as of Nov 20, 4:00 PM EST, down 2.20% on the day. Prices are delayed at least 15 minutes.

Does InMode pay a dividend?

No. InMode does not currently pay a regular cash dividend.

What is INMD's P/E ratio?

INMD trades at a trailing P/E ratio of 10.44 and a forward P/E of 9.15.

Who is InMode's CEO?

Mr. Moshe Mizrahy is the chief executive officer of InMode Ltd., which has about 660 employees.

Has INMD ever split its stock?

Yes. The most recent INMD stock split was a 2-for-1 split on Oct 1, 2021.

What is the INMD 52-week high?

The 52-week high for INMD is $16.67 and the 52-week low is $12.40. The stock is currently 25.5% below its high.

Compare INMD